swisspartners’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | $1.01M | Hold |
5,600
| – | – | 1.28% | 28 |
|
2022
Q3 | $662K | Sell |
5,600
-1,300
| -19% | -$154K | 0.69% | 38 |
|
2022
Q2 | $1.02M | Sell |
6,900
-1,750
| -20% | -$258K | 0.97% | 28 |
|
2022
Q1 | $1.49M | Buy |
8,650
+2,250
| +35% | +$388K | 1.18% | 27 |
|
2021
Q4 | $1.65M | Buy |
6,400
+800
| +14% | +$206K | 1.17% | 27 |
|
2021
Q3 | $2.16M | Sell |
5,600
-400
| -7% | -$154K | 1.67% | 18 |
|
2021
Q2 | $1.41M | Sell |
6,000
-330
| -5% | -$77.6K | 1% | 31 |
|
2021
Q1 | $830K | Sell |
6,330
-1,670
| -21% | -$219K | 0.67% | 38 |
|
2020
Q4 | $822K | Buy |
+8,000
| New | +$822K | 0.72% | 39 |
|